Coenen HH - Search Results

1

Role of O-(2-18F-fluoroethyl)-L-tyrosine PET as a diagnostic tool for detection of malignant progression in patients with low-grade glioma.

Galldiks N, Stoffels G, Ruge MI, Rapp M, Sabel M, Reifenberger G, Erdem Z, Shah NJ, Fink GR, Coenen HH, Langen KJ. Galldiks N, et al. Among authors: coenen hh. J Nucl Med. 2013 Dec;54(12):2046-54. doi: 10.2967/jnumed.113.123836. Epub 2013 Oct 24. J Nucl Med. 2013. PMID: 24159047 Free article.

2

Differential uptake of O-(2-18F-fluoroethyl)-L-tyrosine, L-3H-methionine, and 3H-deoxyglucose in brain abscesses.

Salber D, Stoffels G, Pauleit D, Oros-Peusquens AM, Shah NJ, Klauth P, Hamacher K, Coenen HH, Langen KJ. Salber D, et al. Among authors: coenen hh. J Nucl Med. 2007 Dec;48(12):2056-62. doi: 10.2967/jnumed.107.046615. Epub 2007 Nov 15. J Nucl Med. 2007. PMID: 18006612 Free article.

3

Comparison of (18)F-FET PET and 5-ALA fluorescence in cerebral gliomas.

Floeth FW, Sabel M, Ewelt C, Stummer W, Felsberg J, Reifenberger G, Steiger HJ, Stoffels G, Coenen HH, Langen KJ. Floeth FW, et al. Among authors: coenen hh. Eur J Nucl Med Mol Imaging. 2011 Apr;38(4):731-41. doi: 10.1007/s00259-010-1690-z. Epub 2010 Dec 10. Eur J Nucl Med Mol Imaging. 2011. PMID: 21153408 Clinical Trial.

4

Dual-time-point O-(2-[(18)F]fluoroethyl)-L-tyrosine PET for grading of cerebral gliomas.

Lohmann P, Herzog H, Rota Kops E, Stoffels G, Judov N, Filss C, Galldiks N, Tellmann L, Weiss C, Sabel M, Coenen HH, Shah NJ, Langen KJ. Lohmann P, et al. Among authors: coenen hh. Eur Radiol. 2015 Oct;25(10):3017-24. doi: 10.1007/s00330-015-3691-6. Epub 2015 Mar 27. Eur Radiol. 2015. PMID: 25813014

5

3-[(123)I]Iodo-alpha-methyl-L-tyrosine: uptake mechanisms and clinical applications.

Langen KJ, Pauleit D, Coenen HH. Langen KJ, et al. Among authors: coenen hh. Nucl Med Biol. 2002 Aug;29(6):625-31. doi: 10.1016/s0969-8051(02)00328-1. Nucl Med Biol. 2002. PMID: 12234586 Review.

6

O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas.

Pauleit D, Floeth F, Hamacher K, Riemenschneider MJ, Reifenberger G, Müller HW, Zilles K, Coenen HH, Langen KJ. Pauleit D, et al. Among authors: coenen hh. Brain. 2005 Mar;128(Pt 3):678-87. doi: 10.1093/brain/awh399. Epub 2005 Feb 2. Brain. 2005. PMID: 15689365

7

PET with O-(2-18F-Fluoroethyl)-L-Tyrosine in peripheral tumors: first clinical results.

Pauleit D, Stoffels G, Schaden W, Hamacher K, Bauer D, Tellmann L, Herzog H, Bröer S, Coenen HH, Langen KJ. Pauleit D, et al. Among authors: coenen hh. J Nucl Med. 2005 Mar;46(3):411-6. J Nucl Med. 2005. PMID: 15750152 Free article. Clinical Trial.

8

18F-CPFPX PET identifies changes in cerebral A1 adenosine receptor density caused by glioma invasion.

Bauer A, Langen KJ, Bidmon H, Holschbach MH, Weber S, Olsson RA, Coenen HH, Zilles K. Bauer A, et al. Among authors: coenen hh. J Nucl Med. 2005 Mar;46(3):450-4. J Nucl Med. 2005. PMID: 15750158 Free article.

9

18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer.

Pauleit D, Zimmermann A, Stoffels G, Bauer D, Risse J, Flüss MO, Hamacher K, Coenen HH, Langen KJ. Pauleit D, et al. Among authors: coenen hh. J Nucl Med. 2006 Feb;47(2):256-61. J Nucl Med. 2006. PMID: 16455631 Free article. Clinical Trial.

10

O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.

Langen KJ, Hamacher K, Weckesser M, Floeth F, Stoffels G, Bauer D, Coenen HH, Pauleit D. Langen KJ, et al. Among authors: coenen hh. Nucl Med Biol. 2006 Apr;33(3):287-94. doi: 10.1016/j.nucmedbio.2006.01.002. Nucl Med Biol. 2006. PMID: 16631076 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters